Relationship between adipocytokines and cardiovascular risk factors in patients with type 2 diabetes mellitus

被引：84

作者：

Uslu, Sema ^{[1
]}

Kebapci, Nur ^{[2
]}

Kara, Mehmet ^{[1
]}

Bal, Cengiz ^{[3
]}

机构：

[1] Eskisehir Osmangazi Univ, Sch Med, Dept Med Biochem, TR-26480 Eskisehir, Turkey

[2] Eskisehir Osmangazi Univ, Sch Med, Dept Endocrinol, TR-26480 Eskisehir, Turkey

[3] Eskisehir Osmangazi Univ, Sch Med, Dept Biostat, TR-26480 Eskisehir, Turkey

来源：

EXPERIMENTAL AND THERAPEUTIC MEDICINE | 2012年 / 4卷 / 01期

关键词：

adipocytokines; cardiovascular risk markers; type 2 diabetes mellitus; INSULIN-RESISTANCE; ASYMMETRIC DIMETHYLARGININE; HOMOCYSTEINE LEVELS; METABOLIC SYNDROME; ADIPONECTIN LEVELS; JAPANESE PATIENTS; OXIDATIVE STRESS; SERUM VISFATIN; LEPTIN; DISEASE;

D O I：

10.3892/etm.2012.557

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

The aim of this study was to explore the relationship between serum profiles of adiponectin, leptin, resistin and visfatin and traditional and non-traditional cardiovascular risk factors in patients with type 2 diabetes mellitus (T2DM). A total of 85 patients with T2DM and 30 non-diabetic controls were enrolled in the study. Levels of adipocytokines (adiponectin, leptin, resistin and visfatin), lipids (total cholesterol, triglycerides), lipoproteins [HDL-cholesterol, LDL-cholesterol, lipoprotein (a)], apolipoproteins (Apo-A1 and Apo-B), non-traditional cardiovascular risk markers [asymmetric dimethylarginine (ADMA), homocysteine] and the inflammatory marker hs-CRP were measured, and anthropometric variables were determined. Serum adiponectin levels were decreased and leptin, resistin and visfatin levels were increased in T2DM patients compared to controls. They were associated with obesity (BM I), insulin resistance (HOMA-IR) and various markers of glucose/lipid profile, inflammation and endothelial dysfunction markers. These results suggest that decreased serum adiponectin and increased leptin, resistin and visfatin levels in T2DM may be novel biochemical risk factors for cardiovascular complications.

引用

页码：113 / 120

页数：8

共 50 条

[41] The influence of obesity on the oxidative stress status and the concentration of leptin in type 2 diabetes mellitus patients [J].

Stefanovic, Aleksandra ;

Kotur-Stevuljevic, Jelena ;

Spasic, Slavica ;

Bogavac-Stanojevic, Natasa ;

Bujisic, Nada .

DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 (01) :156-163

[42] Hyperresistinemia is associated with coexistence of hypertension and type 2 diabetes [J].

Takata, Yasunori ;

Osawa, Haruhiko ;

Kurata, Mie ;

Kurokawa, Maki ;

Yamauchi, Junko ;

Ochi, Masaaki ;

Nishida, Wataru ;

Okura, Takafumi ;

Higaki, Jitsuo ;

Makino, Hideichi .

HYPERTENSION, 2008, 51 (02) :534-539

[43] Associations between leptin and the leptin adiponectin ratio and incident Type 2 diabetes in middle-aged men and women: results from the MONICA/KORA Augsburg Study 1984-2002 [J].

Thorand, B. ;

Zierer, A. ;

Baumert, J. ;

Meisinger, C. ;

Herder, C. ;

Koenig, W. .

DIABETIC MEDICINE, 2010, 27 (09) :1004-1011

[44] Serum resistin level is associated with insulin sensitivity in Japanese patients with type 2 diabetes mellitus [J].

Tokuyama, Yoshiharu ;

Osawa, Haruhiko ;

Ishizuka, Toshiharu ;

Onuma, Hiroshi ;

Matsui, Kana ;

Egashira, Toru ;

Makino, Hideichi ;

Kanatsuka, Azuma .

METABOLISM-CLINICAL AND EXPERIMENTAL, 2007, 56 (05) :693-698

[45] Adiponectin is an important determinant of ApoA-I catabolism [J].

Verges, Bruno ;

Petit, Jean Michel ;

Duvillard, Laurence ;

Dautin, Guillaume ;

Florentin, Emmanuel ;

Galland, Francoise ;

Gambert, Philippe .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (06) :1364-1369

[46] Homocysteine suppresses lipolysis in adipocytes by activating the AMPK pathway [J].

Wang, Zhigang ;

Pini, Maria ;

Yao, Tong ;

Zhou, Zhanxiang ;

Sun, Changhao ;

Fantuzzi, Giamila ;

Song, Zhenyuan .

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2011, 301 (04) :E703-E712

[47] Plasma leptin: Associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease [J].

Wannamethee, S. Goya ;

Tchernova, Julia ;

Whincup, Peter ;

Lowe, Gordon D. O. ;

Kelly, Anne ;

Rumley, Ann ;

Wallace, A. Michael ;

Sattar, Naveed .

ATHEROSCLEROSIS, 2007, 191 (02) :418-426

[48] Leptin, triglycerides, and interleukin 6 are independently associated with C-reactive protein in Japanese type 2 diabetic patients [J].

Yanagawa, Takiko ;

Taniguchi, Ataru ;

Fukushima, Mitsuo ;

Nakai, Yoshikatsu ;

Nagasaka, Shoichiro ;

Ohgushi, Minako ;

Matsumoto, Kazunari ;

Kuroe, Akira ;

Ohya, Michihiro ;

Seino, Yutaka .

DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 75 (01) :2-6

[49] Intensive treatment of risk factors in patients with type-2 diabetes mellitus is associated with improvement of endothelial function coupled with a reduction in the levels of plasma asymmetric dimethylarginine and endogenous inhibitor of nitric oxide synthase [J].

Yasuda, S ;

Miyazaki, S ;

Kanda, M ;

Goto, Y ;

Suzuki, M ;

Harano, Y ;

Nonogi, H .

EUROPEAN HEART JOURNAL, 2006, 27 (10) :1159-1165

[50] Serum CRP levels are equally elevated in newly diagnosed type 2 diabetes and impaired glucose tolerance and related to adiponectin levels and insulin sensitivity [J].

Yuan, Guoyue ;

Zhou, Libin ;

Tang, Jinfeng ;

Yang, Ying ;

Gu, Weiqiong ;

Li, Fengying ;

Hong, Jie ;

Gu, Yanyun ;

Li, Xiaoying ;

Ning, Guang ;

Chen, Mingdao .

DIABETES RESEARCH AND CLINICAL PRACTICE, 2006, 72 (03) :244-250

← 1 2 3 4 5 →